Exactly Trding , -- so far Leronlimab has no serious side effects .

--and yes , so far no cure for HIV , but treatment with once a week SC injection , when patients so far didn't develop resistance , working on resistant HIV patients , and so far without one serious side effect is something I am proud of ....

And in combo with 350 mg dose we had 81% efficacy , in contrary to Ibalizumab 43% approved by FDA ...

And our mono improved dramatically when we started to use longer overlap time , and I believe doing Receptor Occupancy test , will improve it so much more ....

And Gilead is so proud with Truvada as a PrEP ,... well , by now we know that during this treatment some patients became infected with HIV, being on Tuvada ,
and we know that it has many side effects...and may produce resistance , and dont cover resistant HIV ...
One of the side effect is NASH , we know by now that Tenofovir might be a big problem.
And about 70% drugs in HAART inlcuding Tenofovir ........

So Gilead , change dose and formulation of Tenofovir in new PrEP , new drug Descovy, still with very many side effects including :
Boxed warning : Risk of drug resistance , and post treatment acute exacerbation of Hepatitis B ...and many others ....please Google ....

And with our cancer patients , I know it is hard to believe , we need to wait for some more patients , but so far I don't know any cancer drugs with this results , and without one serious side effects ...
I am waiting for few more patients , hopefully very soon since IRB was approved November 12.

And in NASH , about 90% reduction of fatty infiltration , and reduction of liver fibrosis , make imo Leronlimab without side effects a very attractive treatment !!!!

And lets not forget patients with HIV generally have more liver problems/NASH especially on HAART..
and we also see cancers ,
hopefully all this will be help by Leronlimab...


WOW , how one can not be exited !!!!



All IMO as always.